A synthetic peptide for use as a blocking control in assays to test for specificity of MAGEA11 antibody, Alternative Names: MAGEA11 control peptide, MAGEA11 antibody Blocking Peptide, Anti-MAGEA11 Blocking Peptide, melanoma antigen family A, 11 Blocking Peptide, CT1.11 Blocking Peptide, MAGE-11 Blocking Peptide, MAGE11 Blocking Peptide, MAGEA-11 Blocking Peptide, MGC10511 Blocking Peptide, MAGEA11, MAGEA-11, MAGEA 11, MAGEA-11 Blocking Peptide, MAGEA 11 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
MAGEA11
(Melanoma Antigen Family A, 11 (MAGEA11))
Hintergrund
This gene is a member of the MAGEA gene family. The members of this family encode proteins with 50 to 80 % sequence identity to each other. The promoters and first exons of the MAGEA genes show considerable variability, suggesting that the existence of this gene family enables the same function to be expressed under different transcriptional controls. The MAGEA genes are clustered at chromosomal location Xq28. They have been implicated in some hereditary disorders, such as dyskeratosis congenita. Two transcript variants encoding different isoforms have been found for this gene.